Compile Data Set for Download or QSAR
Report error Found 25 Enz. Inhib. hit(s) with all data for entry = 3494
TargetGlycogen phosphorylase, liver form(Human)
Astellas Pharma

LigandPNGBDBM35636(5-chloroindolecarboxamide, 13a)
Affinity DataIC50: 250nMpH: 6.8 T: 2°CAssay Description:The activity of recombinant human liver GPa in the forward direction was measured by monitoring the production of NADPH. Enzyme activity was assayed...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/15/2009
Entry Details Article
PubMed
TargetGlycogen phosphorylase, liver form(Human)
Astellas Pharma

LigandPNGBDBM35633(5-chloroindolecarboxamide, 9h)
Affinity DataIC50: 340nMpH: 6.8 T: 2°CAssay Description:The activity of recombinant human liver GPa in the forward direction was measured by monitoring the production of NADPH. Enzyme activity was assayed...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/15/2009
Entry Details Article
PubMed
TargetGlycogen phosphorylase, liver form(Human)
Astellas Pharma

LigandPNGBDBM35628(5-chloroindolecarboxamide, 9c)
Affinity DataIC50: 420nMpH: 6.8 T: 2°CAssay Description:The activity of recombinant human liver GPa in the forward direction was measured by monitoring the production of NADPH. Enzyme activity was assayed...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/15/2009
Entry Details Article
PubMed
TargetGlycogen phosphorylase, liver form(Human)
Astellas Pharma

LigandPNGBDBM35638(5-chloroindolecarboxamide, 13c)
Affinity DataIC50: 440nMpH: 6.8 T: 2°CAssay Description:The activity of recombinant human liver GPa in the forward direction was measured by monitoring the production of NADPH. Enzyme activity was assayed...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/15/2009
Entry Details Article
PubMed
TargetGlycogen phosphorylase, liver form(Human)
Astellas Pharma

LigandPNGBDBM35622(5-chloroindolecarboxamide, 2f)
Affinity DataIC50: 900nMpH: 6.8 T: 2°CAssay Description:The activity of recombinant human liver GPa in the forward direction was measured by monitoring the production of NADPH. Enzyme activity was assayed...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/15/2009
Entry Details Article
PubMed
TargetGlycogen phosphorylase, liver form(Human)
Astellas Pharma

LigandPNGBDBM35346(5-CHLORO-1H-INDOLE-2-CARBOXYLIC ACID [1-(4-FLUOROB...)
Affinity DataIC50: 920nMpH: 6.8 T: 2°CAssay Description:The activity of recombinant human liver GPa in the forward direction was measured by monitoring the production of NADPH. Enzyme activity was assayed...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/15/2009
Entry Details Article
PubMed
TargetGlycogen phosphorylase, liver form(Human)
Astellas Pharma

LigandPNGBDBM35629(5-chloroindolecarboxamide, 9d)
Affinity DataIC50: 1.10E+3nMpH: 6.8 T: 2°CAssay Description:The activity of recombinant human liver GPa in the forward direction was measured by monitoring the production of NADPH. Enzyme activity was assayed...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/15/2009
Entry Details Article
PubMed
TargetGlycogen phosphorylase, liver form(Human)
Astellas Pharma

LigandPNGBDBM35618(5-chloroindolecarboxamide, 2b)
Affinity DataIC50: 1.20E+3nMpH: 6.8 T: 2°CAssay Description:The activity of recombinant human liver GPa in the forward direction was measured by monitoring the production of NADPH. Enzyme activity was assayed...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/15/2009
Entry Details Article
PubMed
TargetGlycogen phosphorylase, liver form(Human)
Astellas Pharma

LigandPNGBDBM35617(5-chloroindolecarboxamide, 2a)
Affinity DataIC50: 1.60E+3nMpH: 6.8 T: 2°CAssay Description:The activity of recombinant human liver GPa in the forward direction was measured by monitoring the production of NADPH. Enzyme activity was assayed...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/15/2009
Entry Details Article
PubMed
TargetGlycogen phosphorylase, liver form(Human)
Astellas Pharma

LigandPNGBDBM35635(5-chloroindolecarboxamide, 9j)
Affinity DataIC50: 1.70E+3nMpH: 6.8 T: 2°CAssay Description:The activity of recombinant human liver GPa in the forward direction was measured by monitoring the production of NADPH. Enzyme activity was assayed...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/15/2009
Entry Details Article
PubMed
TargetGlycogen phosphorylase, liver form(Human)
Astellas Pharma

LigandPNGBDBM35634(5-chloroindolecarboxamide, 9i)
Affinity DataIC50: 2.10E+3nMpH: 6.8 T: 2°CAssay Description:The activity of recombinant human liver GPa in the forward direction was measured by monitoring the production of NADPH. Enzyme activity was assayed...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/15/2009
Entry Details Article
PubMed
TargetGlycogen phosphorylase, liver form(Human)
Astellas Pharma

LigandPNGBDBM35630(5-chloroindolecarboxamide, 9e)
Affinity DataIC50: 2.50E+3nMpH: 6.8 T: 2°CAssay Description:The activity of recombinant human liver GPa in the forward direction was measured by monitoring the production of NADPH. Enzyme activity was assayed...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/15/2009
Entry Details Article
PubMed
TargetGlycogen phosphorylase, liver form(Human)
Astellas Pharma

LigandPNGBDBM35626(5-chloroindolecarboxamide, 9a)
Affinity DataIC50: 2.60E+3nMpH: 6.8 T: 2°CAssay Description:The activity of recombinant human liver GPa in the forward direction was measured by monitoring the production of NADPH. Enzyme activity was assayed...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/15/2009
Entry Details Article
PubMed
TargetGlycogen phosphorylase, liver form(Human)
Astellas Pharma

LigandPNGBDBM35640(5-chloroindolecarboxamide, 15b)
Affinity DataIC50: 3.10E+3nMpH: 6.8 T: 2°CAssay Description:The activity of recombinant human liver GPa in the forward direction was measured by monitoring the production of NADPH. Enzyme activity was assayed...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/15/2009
Entry Details Article
PubMed
TargetGlycogen phosphorylase, liver form(Human)
Astellas Pharma

LigandPNGBDBM35627(5-chloroindolecarboxamide, 9b)
Affinity DataIC50: 3.20E+3nMpH: 6.8 T: 2°CAssay Description:The activity of recombinant human liver GPa in the forward direction was measured by monitoring the production of NADPH. Enzyme activity was assayed...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/15/2009
Entry Details Article
PubMed
TargetGlycogen phosphorylase, liver form(Human)
Astellas Pharma

LigandPNGBDBM35632(5-chloroindolecarboxamide, 9g)
Affinity DataIC50: 3.30E+3nMpH: 6.8 T: 2°CAssay Description:The activity of recombinant human liver GPa in the forward direction was measured by monitoring the production of NADPH. Enzyme activity was assayed...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/15/2009
Entry Details Article
PubMed
TargetGlycogen phosphorylase, liver form(Human)
Astellas Pharma

LigandPNGBDBM35624(5-chloroindolecarboxamide, 2h)
Affinity DataIC50: 3.60E+3nMpH: 6.8 T: 2°CAssay Description:The activity of recombinant human liver GPa in the forward direction was measured by monitoring the production of NADPH. Enzyme activity was assayed...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/15/2009
Entry Details Article
PubMed
TargetGlycogen phosphorylase, liver form(Human)
Astellas Pharma

LigandPNGBDBM35637(5-chloroindolecarboxamide, 13b)
Affinity DataIC50: 4.40E+3nMpH: 6.8 T: 2°CAssay Description:The activity of recombinant human liver GPa in the forward direction was measured by monitoring the production of NADPH. Enzyme activity was assayed...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/15/2009
Entry Details Article
PubMed
TargetGlycogen phosphorylase, liver form(Human)
Astellas Pharma

LigandPNGBDBM35623(5-chloroindolecarboxamide, 2g)
Affinity DataIC50: 5.80E+3nMpH: 6.8 T: 2°CAssay Description:The activity of recombinant human liver GPa in the forward direction was measured by monitoring the production of NADPH. Enzyme activity was assayed...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/15/2009
Entry Details Article
PubMed
TargetGlycogen phosphorylase, liver form(Human)
Astellas Pharma

LigandPNGBDBM35621(5-chloroindolecarboxamide, 2e)
Affinity DataIC50: 6.20E+3nMpH: 6.8 T: 2°CAssay Description:The activity of recombinant human liver GPa in the forward direction was measured by monitoring the production of NADPH. Enzyme activity was assayed...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/15/2009
Entry Details Article
PubMed
TargetGlycogen phosphorylase, liver form(Human)
Astellas Pharma

LigandPNGBDBM35631(5-chloroindolecarboxamide, 9f)
Affinity DataIC50: 7.40E+3nMpH: 6.8 T: 2°CAssay Description:The activity of recombinant human liver GPa in the forward direction was measured by monitoring the production of NADPH. Enzyme activity was assayed...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/15/2009
Entry Details Article
PubMed
TargetGlycogen phosphorylase, liver form(Human)
Astellas Pharma

LigandPNGBDBM35625(5-chloroindolecarboxamide, 2i)
Affinity DataIC50: 1.00E+4nMpH: 6.8 T: 2°CAssay Description:The activity of recombinant human liver GPa in the forward direction was measured by monitoring the production of NADPH. Enzyme activity was assayed...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/15/2009
Entry Details Article
PubMed
TargetGlycogen phosphorylase, liver form(Human)
Astellas Pharma

LigandPNGBDBM35620(5-chloroindolecarboxamide, 2d)
Affinity DataIC50: 1.00E+4nMpH: 6.8 T: 2°CAssay Description:The activity of recombinant human liver GPa in the forward direction was measured by monitoring the production of NADPH. Enzyme activity was assayed...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/15/2009
Entry Details Article
PubMed
TargetGlycogen phosphorylase, liver form(Human)
Astellas Pharma

LigandPNGBDBM35619(5-chloroindolecarboxamide, 2c)
Affinity DataIC50: 1.00E+4nMpH: 6.8 T: 2°CAssay Description:The activity of recombinant human liver GPa in the forward direction was measured by monitoring the production of NADPH. Enzyme activity was assayed...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/15/2009
Entry Details Article
PubMed
TargetGlycogen phosphorylase, liver form(Human)
Astellas Pharma

LigandPNGBDBM35639(5-chloroindolecarboxamide, 15a)
Affinity DataIC50: 1.00E+4nMpH: 6.8 T: 2°CAssay Description:The activity of recombinant human liver GPa in the forward direction was measured by monitoring the production of NADPH. Enzyme activity was assayed...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/15/2009
Entry Details Article
PubMed